|
⚲
|
| Keyboard |
| Ellias Helen K
✚
|
|
|---|---|
| CIK # | 0002001600 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002001600] | |
| 4 | [0002001600] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Ellias Helen K |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2025-12-16 | Grant | 150,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2024-11-01 | Grant | 35,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Stock Option (right to buy) · derivative
|
2024-11-01 | Grant | 20,000 | $0.00 | |
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2023-11-24 | Option exercise | 2,857,142 | ||
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-11-24 | Option exercise | 1,800 | $1,000.00 | 1,800,000 |